Catalent, Inc. (NYSE:CTLT), the leading global provider of advanced
delivery technologies and development solutions for drugs, biologics and
consumer health products, today announced that Matthew Walsh, Executive
Vice President & Chief Financial Officer, will present at the following
two investor conferences in May.
-
The Deutsche Bank 40th Annual Health Care Conference in
Boston, MA, on Thursday, May 7, 2015 at 12:50 p.m. ET.
-
The Bank of America Merrill Lynch 2015 Health Care Conference in Las
Vegas, NV, on Tuesday, May 12, 2015 at 11:20 a.m. PT.
A live webcast of Catalent’s presentation will be accessible through the
Company’s website at http://investor.catalent.com
and will be available for replay for 90 days following each event.
About Catalent, Inc.
Catalent, Inc. (NYSE:CTLT) is the leading global provider of advanced
delivery technologies and development solutions for drugs, biologics and
consumer health products. With over 80 years serving the industry,
Catalent has proven expertise in bringing more customer products to
market faster, enhancing product performance and ensuring reliable
clinical and commercial product supply. Catalent employs approximately
8,000 people, including over 1,000 scientists, at 30 facilities across 5
continents and in fiscal 2014 generated more than $1.8 billion in annual
revenue. Catalent is headquartered in Somerset, N.J. For more
information, please visit www.catalent.com.
More products. Better treatments. Reliably supplied.™
Investor Contact:
Thomas Castellano, Catalent, Inc.
Jeremy Feffer, Bertner Advisors, LLC
732-537-6325
investors@catalent.com